Background: Virilization is associated with either ovarian causes, inc
luding polycystic ovary syndrome, hyperthecosis, and ovarian tumor, or
with adrenal causes, including tumors and congenital adrenal hyperpla
sia. In establishing the diagnosis, levels of dehydroepiandresterone s
ulfate, testosterone, and 17 alpha-hydroxyprogesterone (17-OHP), with
their response to dexamethasone treatment, should be assessed; and, wh
ere indicated, computerized tomography, ultrasound, and selective veno
us catheterization should be undertaken. Case Report and Results: A 21
-year-old woman presented with a 17-year history of early accelerated
linear growth and virilization. During this time, a putative diagnosis
of nonclassic congenital adrenal hyperplasia had been made, and she h
ad been treated with glucocorticoids, with no regression in virilizati
on, for 8 years. On presentation to our group, the failure of low- and
high-dose dexamethasone suppression tests to decrease blood levels of
testosterone and 17-OHP, combined with a relatively low blood level o
f corticotropin, led us to investigate an androgen-secreting tumor of
ovarian origin. When ultrasonography and computerized tomography of th
e ovaries and adrenal glands displayed no abnormality, selective venou
s catheterization was performed, revealing an abnormal ovarian-periphe
ral gradient for testosterone, 17-OHP, estradiol, and androstenedione
in the right ovarian vein. On exploratory laparotomy, a neoplasm adjac
ent to the right ovary was resected and was found to be a steroid cell
tumor of the ovary not otherwise specified, one of the rarest tumors
causing virilization in children. Symptomatic resolution followed tumo
r removal. Conclusion; Selective ovarian and adrenal venous catheteriz
ation for hormone assays is an efficient method of identification and
localization of an androgen source in virilizing syndromes when noninv
asive methods fail.